Literature DB >> 33268447

Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations.

Jian Carrot-Zhang1,2,3, Giovanny Soca-Chafre4, Nick Patterson2,3, Aaron R Thorner1, Anwesha Nag1, Jacqueline Watson1,2, Giulio Genovese2,3, July Rodriguez5, Maya K Gelbard1, Luis Corrales-Rodriguez6,7, Yoichiro Mitsuishi8, Gavin Ha9, Joshua D Campbell10, Geoffrey R Oxnard1, Oscar Arrieta11,12, Andres F Cardona13,14, Alexander Gusev15,2,16, Matthew Meyerson15,2,3.   

Abstract

Inherited lung cancer risk, particularly in nonsmokers, is poorly understood. Genomic and ancestry analysis of 1,153 lung cancers from Latin America revealed striking associations between Native American ancestry and their somatic landscape, including tumor mutational burden, and specific driver mutations in EGFR, KRAS, and STK11. A local Native American ancestry risk score was more strongly correlated with EGFR mutation frequency compared with global ancestry correlation, suggesting that germline genetics (rather than environmental exposure) underlie these disparities. SIGNIFICANCE: The frequency of somatic EGFR and KRAS mutations in lung cancer varies by ethnicity, but we do not understand why. Our study suggests that the variation in EGFR and KRAS mutation frequency is associated with genetic ancestry and suggests further studies to identify germline alleles that underpin this association.See related commentary by Gomez et al., p. 534.This article is highlighted in the In This Issue feature, p. 521. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33268447      PMCID: PMC7933062          DOI: 10.1158/2159-8290.CD-20-1165

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  50 in total

1.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

2.  RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference.

Authors:  Brian K Maples; Simon Gravel; Eimear E Kenny; Carlos D Bustamante
Journal:  Am J Hum Genet       Date:  2013-08-01       Impact factor: 11.025

3.  Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering.

Authors:  Sharon R Browning; Brian L Browning
Journal:  Am J Hum Genet       Date:  2007-09-21       Impact factor: 11.025

4.  EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authors:  J Guillermo Paez; Pasi A Jänne; Jeffrey C Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J Kaye; Neal Lindeman; Titus J Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J Eck; William R Sellers; Bruce E Johnson; Matthew Meyerson
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

5.  EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII).

Authors:  Anita Midha; Simon Dearden; Rose McCormack
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

6.  Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.

Authors:  Joshua D Campbell; Anton Alexandrov; Jaegil Kim; Jeremiah Wala; Alice H Berger; Chandra Sekhar Pedamallu; Sachet A Shukla; Guangwu Guo; Angela N Brooks; Bradley A Murray; Marcin Imielinski; Xin Hu; Shiyun Ling; Rehan Akbani; Mara Rosenberg; Carrie Cibulskis; Aruna Ramachandran; Eric A Collisson; David J Kwiatkowski; Michael S Lawrence; John N Weinstein; Roel G W Verhaak; Catherine J Wu; Peter S Hammerman; Andrew D Cherniack; Gad Getz; Maxim N Artyomov; Robert Schreiber; Ramaswamy Govindan; Matthew Meyerson
Journal:  Nat Genet       Date:  2016-05-09       Impact factor: 38.330

7.  Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations.

Authors:  Letícia Ferro Leal; Flávia Escremim de Paula; Pedro De Marchi; Luciano de Souza Viana; Gustavo Dix Junqueira Pinto; Carolina Dias Carlos; Gustavo Noriz Berardinelli; José Elias Miziara; Carlos Maciel da Silva; Eduardo Caetano Albino Silva; Rui Pereira; Marco Antonio de Oliveira; Cristovam Scapulatempo-Neto; Rui Manuel Reis
Journal:  Sci Rep       Date:  2019-03-01       Impact factor: 4.379

8.  Mechanisms and therapeutic implications of hypermutation in gliomas.

Authors:  Mehdi Touat; Yvonne Y Li; Adam N Boynton; Liam F Spurr; J Bryan Iorgulescu; Craig L Bohrson; Isidro Cortes-Ciriano; Cristina Birzu; Jack E Geduldig; Kristine Pelton; Mary Jane Lim-Fat; Sangita Pal; Ruben Ferrer-Luna; Shakti H Ramkissoon; Frank Dubois; Charlotte Bellamy; Naomi Currimjee; Juliana Bonardi; Kenin Qian; Patricia Ho; Seth Malinowski; Leon Taquet; Robert E Jones; Aniket Shetty; Kin-Hoe Chow; Radwa Sharaf; Dean Pavlick; Lee A Albacker; Nadia Younan; Capucine Baldini; Maïté Verreault; Marine Giry; Erell Guillerm; Samy Ammari; Frédéric Beuvon; Karima Mokhtari; Agusti Alentorn; Caroline Dehais; Caroline Houillier; Florence Laigle-Donadey; Dimitri Psimaras; Eudocia Q Lee; Lakshmi Nayak; J Ricardo McFaline-Figueroa; Alexandre Carpentier; Philippe Cornu; Laurent Capelle; Bertrand Mathon; Jill S Barnholtz-Sloan; Arnab Chakravarti; Wenya Linda Bi; E Antonio Chiocca; Katie Pricola Fehnel; Sanda Alexandrescu; Susan N Chi; Daphne Haas-Kogan; Tracy T Batchelor; Garrett M Frampton; Brian M Alexander; Raymond Y Huang; Azra H Ligon; Florence Coulet; Jean-Yves Delattre; Khê Hoang-Xuan; David M Meredith; Sandro Santagata; Alex Duval; Marc Sanson; Andrew D Cherniack; Patrick Y Wen; David A Reardon; Aurélien Marabelle; Peter J Park; Ahmed Idbaih; Rameen Beroukhim; Pratiti Bandopadhayay; Franck Bielle; Keith L Ligon
Journal:  Nature       Date:  2020-04-15       Impact factor: 49.962

9.  Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients.

Authors:  J P Koivunen; J Kim; J Lee; A M Rogers; J O Park; X Zhao; K Naoki; I Okamoto; K Nakagawa; B Y Yeap; M Meyerson; K-K Wong; W G Richards; D J Sugarbaker; B E Johnson; P A Jänne
Journal:  Br J Cancer       Date:  2008-07-01       Impact factor: 7.640

10.  Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors.

Authors:  Jaegil Kim; Kent W Mouw; Paz Polak; Lior Z Braunstein; Atanas Kamburov; David J Kwiatkowski; Jonathan E Rosenberg; Eliezer M Van Allen; Alan D'Andrea; Gad Getz
Journal:  Nat Genet       Date:  2016-04-25       Impact factor: 38.330

View more
  13 in total

1.  Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors.

Authors:  Amin H Nassar; Elio Adib; Sarah Abou Alaiwi; Talal El Zarif; Stefan Groha; Elie W Akl; Pier Vitale Nuzzo; Tarek H Mouhieddine; Tomin Perea-Chamblee; Kodi Taraszka; Habib El-Khoury; Muhieddine Labban; Christopher Fong; Kanika S Arora; Chris Labaki; Wenxin Xu; Guru Sonpavde; Robert I Haddad; Kent W Mouw; Marios Giannakis; F Stephen Hodi; Noah Zaitlen; Adam J Schoenfeld; Nikolaus Schultz; Michael F Berger; Laura E MacConaill; Guruprasad Ananda; David J Kwiatkowski; Toni K Choueiri; Deborah Schrag; Jian Carrot-Zhang; Alexander Gusev
Journal:  Cancer Cell       Date:  2022-09-29       Impact factor: 38.585

2.  Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.

Authors:  Philip C Mack; Michael I Klein; Kristin L Ayers; Xiang Zhou; Sunny Guin; Marc Fink; Michael Rossi; Hussam Ai-Kateb; Timmy O'Connell; Feras M Hantash; William K Oh; Scott Newman; Eric E Schadt; Rong Chen; Fred R Hirsch
Journal:  Oncologist       Date:  2022-06-08       Impact factor: 5.837

3.  Cells with Cancer-associated Mutations Overtake Our Tissues as We Age.

Authors:  Edward J Evans; James DeGregori
Journal:  Aging Cancer       Date:  2021-10-21

4.  Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.

Authors:  Semanti Mukherjee; Chaitanya Bandlamudi; Matthew D Hellmann; Yelena Kemel; Esther Drill; Hira Rizvi; Kaitlyn Tkachuk; Aliya Khurram; Michael F Walsh; Marjorie G Zauderer; Diana Mandelker; Sabine Topka; Ahmet Zehir; Preethi Srinivasan; Myvizhi Esai Selvan; Maria I Carlo; Karen A Cadoo; Alicia Latham; Jada G Hamilton; Ying L Liu; Steven M Lipkin; Sami Belhadj; Gareth L Bond; Zeynep H Gümüş; Robert J Klein; Marc Ladanyi; David B Solit; Mark E Robson; David R Jones; Mark G Kris; Joseph Vijai; Zsofia K Stadler; Christopher I Amos; Barry S Taylor; Michael F Berger; Charles M Rudin; Kenneth Offit
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

5.  Towards the understanding of the genetics of somatic mutations.

Authors:  Xiwei Sun; Jian Yang
Journal:  Br J Cancer       Date:  2021-04-07       Impact factor: 7.640

6.  Analytical protocol to identify local ancestry-associated molecular features in cancer.

Authors:  Jian Carrot-Zhang; Seunghun Han; Wanding Zhou; Jeffrey S Damrauer; Anab Kemal; Andrew D Cherniack; Rameen Beroukhim
Journal:  STAR Protoc       Date:  2021-09-20

7.  Variation in targetable genomic alterations in non-small cell lung cancer by genetic ancestry, sex, smoking history, and histology.

Authors:  Elio Adib; Amin H Nassar; Sarah Abou Alaiwi; Stefan Groha; Elie W Akl; Lynette M Sholl; Kesi S Michael; Mark M Awad; Pasi A Jӓnne; Alexander Gusev; David J Kwiatkowski
Journal:  Genome Med       Date:  2022-04-15       Impact factor: 15.266

8.  Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.

Authors:  Christopher M Aldrighetti; Andrzej Niemierko; Eliezer Van Allen; Henning Willers; Sophia C Kamran
Journal:  JAMA Netw Open       Date:  2021-11-01

9.  Constructing germline research cohorts from the discarded reads of clinical tumor sequences.

Authors:  Alexander Gusev; Noah Zaitlen; Stefan Groha; Kodi Taraszka; Yevgeniy R Semenov
Journal:  Genome Med       Date:  2021-11-08       Impact factor: 11.117

10.  Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial-Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cells.

Authors:  Pedro Barrios-Bernal; Norma Hernandez-Pedro; Mario Orozco-Morales; Rubí Viedma-Rodríguez; José Lucio-Lozada; Federico Avila-Moreno; Andrés F Cardona; Rafael Rosell; Oscar Arrieta
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.